Details for New Drug Application (NDA): 075435
✉ Email this page to a colleague
The generic ingredient in GABAPENTIN is gabapentin. There are twenty-nine drug master file entries for this compound. Seventy-six suppliers are listed for this compound. Additional details are available on the gabapentin profile page.
Summary for 075435
Tradename: | GABAPENTIN |
Applicant: | Teva Pharms |
Ingredient: | gabapentin |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 100MG | ||||
Approval Date: | Oct 8, 2004 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 300MG | ||||
Approval Date: | Oct 8, 2004 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 400MG | ||||
Approval Date: | Oct 8, 2004 | TE: | RLD: | No |
Complete Access Available with Subscription